Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 901–1,000 of 1,008
The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells
Dai, H., Griffin, N., Bolyard, C. M., Mao, H. C., Zhang, J., Cripe, T. P., Suenaga, T., Arase, H., Nakano, I., Chiocca, E. A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.019 · Cited by 41
“Due to the importance of Fc binding in mediating every facet of immune responses (Nimmerjahn and Ravetch, 2008), screening human proteins that are able to form a ternary complex with IgGFc and human FcgRs or complement may identify auto-antigens, define autoimmune diseases, and uncover the cause of…”
BackgroundInfluentialMale-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease
Kwon, Y.-C., Kim, J.-J., Yun, S. W., Yu, J. J., Yoon, K. L., Lee, K., Kil, H. R., Kim, G. B., Han, M.-K., Song, M. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184248 · Cited by 42
Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells
Burton, O. T., Epp, A., Fanny, M., Miller, S. J., Stranks, A. J., Teague, J. E., Clark, R. A., van de Rijn, M., & Oettgen, H. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01244 · Cited by 43
Garg, A. K., Desikan, R., & Dixit, N. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.030 · Cited by 44
“Previous studies have shown that Ag by itself may not bind with high affinity to Fc γ or complement receptors (Nimmerjahn and Ravetch, 2008; Chan et al., 2015) and therefore may not be efficiently presented on FDCs.”
CARs: Beyond T Cells and T Cell-Derived Signaling Domains
Sievers, N. M., Dörrie, J., & Schaft, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103525 · Cited by 42
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
Perricone, C., Triggianese, P., Bursi, R., Cafaro, G., Bartoloni, E., Chimenti, M. S., Gerli, R., & Perricone, R. (2021) · Microorganisms · doi:10.3390/microorganisms9010121 · Cited by 49
Jin, H., D’Urso, V., Neuteboom, B., McKenna, S. D., Schweickhardt, R. L., Gross, A. W., Fomekong‐Nanfack, Y., Paoletti, A., Carter, C., Toleikis, L., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1958590 · Cited by 43
“These receptors are expressed on various types of immune cells that can be recruited to tumors through FcγR-Fc interactions with antibody-bound targets.(9) Recruited immune cells can then elicit or mediate immunologic activities, including endocytosis and phagocytosis.”
BackgroundAvila-Pedretti, G., Tornero, J., Fernández‐Nebro, A., Blanco, F. J., González‐Álvaro, I., Cañete, J. D. D., Maymó, J., Alperiz, M., Fernández‐Gutiérrez, B., Olivé, À., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122088 · Cited by 42
“In these cells, FCGRs bind to extracellular IgG immunogloblins, and this binding can lead to either cell activation or repression [13,14,15].”
BackgroundChan, K. R., Ong, E. Z., Mok, D. Z., & Ooi, E. E. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1079127 · Cited by 40
“FcgRIIA and FcgRIIIA, on the other hand, bind strongly to immune complexes but not to monomeric IgG [17] .”
BackgroundGrevers, L. C., de Vries, T. J., Everts, V. E., Verbeek, J. S., van den Berg, W. B., & van Lent, P. L. E. M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201568 · Cited by 40
Boross, P., van Montfoort, N., Stapels, D. A. C., van der Poel, C. E., Bertens, C. J. F., Meeldijk, J., Jansen, J. H. M., Verbeek, J. S., OSSENDORP, F. A., Wubbolts, R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302012 · Cited by 39
Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis
Khodoun, M. V., Kucuk, Z. Y., Strait, R. T., Krishnamurthy, D., Janek, K. C., Clay, C. D., Morris, S. C., & Finkelman, F. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.008 · Cited by 43
FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling
Zhu, Z., Li, R., Li, H., Zhou, T., & Davis, R. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215156110 · Cited by 43
New Insights into Molecular Mechanisms of Immune Complex-Induced Injury in Lung
Ward, P. A., Fattahi, F., & Bosmann, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00086 · Cited by 39
Lee, Y. H., & Bae, S. (2016) · Rheumatology International · doi:10.1007/s00296-016-3476-5 · Cited by 39
Immunoglobulin Glycosylation Effects in Allergy and Immunity
Epp, A., Locker, K. C. S., Herr, A. B., & Strait, R. T. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0658-x · Cited by 45
Roghanian, A., Stopforth, R. J., Dahal, L. N., & Cragg, M. S. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0917-354r · Cited by 46
Mechanisms of inside-out signaling of the high-affinity IgG receptor FcγRI
Brandsma, A. M., Schwartz, S. L., Wester, M. J., Valley, C. C., Blezer, G., Vidarsson, G., Lidke, K. A., ten Broeke, T., Lidke, D. S., & Leusen, J. H. W. (2018) · Science Signaling · doi:10.1126/scisignal.aaq0891 · Cited by 42
“Because of its high affinity, FcRI is constitutively saturated with monomeric IgG, even after extravasation of immune cells or isolation from the blood (2).”
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
Chen, B., Vousden, K. A., Naiman, B. M., Turman, S., Sun, H., Wang, S., Vinall, L., Kemp, B., Kasturiangan, S., Rees, D. G., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213523 · Cited by 40
Hoepel, W., Newling, M., Vogelpoel, L. T. C., Sritharan, L., Hansen, I. S., Kapsenberg, M. L., Baeten, D., Everts, B., & den Dunnen, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00739 · Cited by 45
“FcγRs such as FcγRIIa signal through an ITAM sequence in the cytoplasmic tail, which is a common signaling module used by a variety of receptors, including B cell receptors and T cell receptors, and other members of the Fc receptor family (42, 43).”
BackgroundRolih, V., Caldeira, J. C., Bolli, E., Salameh, A., Conti, L., Barutello, G., Riccardo, F., Magri, J., Lamolinara, A., Parra, K., et al. (2020) · Cancers · doi:10.3390/cancers12061492 · Cited by 39
Good, L., Benner, B. N., & Carson, W. E. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02908-5 · Cited by 42
Hansen, K., Kumar, S., Logronio, K. A., Whelan, S., Qurashi, S., Cheng, H., Drake, A., Tang, M. L., Wall, P., Bernados, D., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02921-8 · Cited by 42
“In addition, although studies with anti-TIGIT mIgG2a demonstrated monotherapy activity in-vivo, mouse models do not mirror the structural diversity and expression pattern of the human Fc receptor systems [36], and thus their translational relevance for human isotype selection is questionable, as exemplified by early c…”
BackgroundSelective Antibody Intervention of Toll-like Receptor 4 Activation through Fc γ Receptor Tethering
Shang, L., Daubeuf, B., Triantafilou, M., Olden, R., Dépis, F., Raby, A., Herren, S., Santos, A. D., Malinge, P., Dunn-Siegrist, I., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537936 · Cited by 39
“of inflammatory mediators, and antibody-dependent cellular cytotoxicity (12).”
Murdaca, G., Negrini, S., Magnani, O., Penza, E., Pellecchio, M., & Puppo, F. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1361404 · Cited by 39
“The –V158 allele binds more avidly to IgG1, IgG2, and IgG3 than to the –F158 allele [47].”
BackgroundSialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury
Zhang, G., Massaad, C. A., Gao, T., Pillai, L., Bogdanova, N., Ghauri, S., & Sheikh, K. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.020 · Cited by 38
“Adaptive autoimmunity uses the powerful effector functions of cells of the innate immune system including monocytes/macrophages to induce target injury in infectious and autoimmune disorders (Nimmerjahn and Ravetch, 2008; Takai, 2002).”
BackgroundTherapeutic antibodies for the prevention and treatment of cancer
Kumar, M., Jalota, A., Sahu, S. K., & Haque, S. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00996-w · Cited by 39
Yang, H., Zhang, Z., Li, J., Wang, K., Zhu, W., & Zeng, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111825 · Cited by 50
“Collectively, these pathways orchestrate the processes of phagocyte recognition, engulfment, and destruction of tumor cells [70,76–78].”
BackgroundWei, Q., Yang, T., Zhang, Z., Wang, F., Yang, Y., Zhu, J., Zhu, X., Li, Y., Xing, Y., Lu, Y., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2021 · Cited by 44
Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies
Kim, J. M., & Ashkenazi, A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131625 · Cited by 43
“…motif (ITIM) that recruits specific phosphatases to oppose signaling by activating FcRs. Innate-immune cells, such as macrophages, monocytes, dendritic cells, mast cells, and granulocytes, express both activating and inhibitory FcRIIB (Amigorena et al., 1992; Nimmerjahn and Ravetch, 2008).”
BackgroundWilson, T. J., Gilfillan, S., & Colonna, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001428 · Cited by 38
Chiu, Y. G., Schwarz, E. M., Li, D., Xu, Y., Sheu, T., Li, J., Bentley, K. L. D. M., Feng, C., Wang, B., Wang, J., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25638 · Cited by 47
Immunotherapy for breast cancer: past, present, and future
Spellman, A., & Tang, S.-C. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9654-9 · Cited by 43
Zhao, B., Zhang, X., Krummenacher, C., Song, S., Gao, L., Zhang, H., Xu, M., Feng, L., Feng, Q., Zeng, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00932 · Cited by 39
Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
Murin, C. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01635 · Cited by 50
“Within the innate cell repertoire, macrophages, monocytes, granulocytes, dendritic cells, and mast cells all express varying combinations of the FcγRs (1, 51).”
BackgroundInfluentialFc Gamma Receptors as Regulators of Bone Destruction in Inflammatory Arthritis
Zuo, Y., & Deng, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688201 · Cited by 41
Rayner, L., Kadkhodayi-Kholghi, N., Heenan, R. K., Gor, J., Dalby, P. A., & Perkins, S. J. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.019 · Cited by 42
Masters, T. A., Sheetz, M. P., & Gauthier, N. C. (2016) · Cytoskeleton · doi:10.1002/cm.21287 · Cited by 42
“The most extensively studied family of phagocytic receptors are the Fc receptors [Nimmerjahn and Ravetch, 2008], which bind to immunoglobulin G (IgG), and activate a zipper-like protrusive engulfment of targets [Swanson, 2008].”
BackgroundEngineering the interactions between a plant‐produced HIV antibody and human Fc receptors
Stelter, S., Paul, M. J., Teh, A. Y., Grandits, M., Altmann, F., Vanier, J., Bardor, M., Castilho, A., Allen, R. L., & K‐C., J. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13207 · Cited by 42
“Serum antibodies naturally demonstrate a high level of glycan heterogeneity, exhibiting as many as 30–40 different glycoforms (Nimmerjahn and Ravetch, 2008; Stadlmann et al., 2008).”
BackgroundAberrant Immunoglobulin G Glycosylation in Multiple Sclerosis
Kennedy, P. G. E., Graner, M. W., Pointon, T., Li, X., Tanimoto, K., Dennison, K., Im, G., Fringuello, A. R., Zhou, W., Graner, A. N., et al. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09996-1 · Cited by 41
Niknami, M., Wang, M., Nguyen, T. D., & Pollard, J. D. (2013) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12022 · Cited by 37
“Further, only Fcγ RIIB is present on B cells and transduces an inhibitory signal, when interacting with the B cell receptor, preventing B cells from entering the germinal centre and transforming into plasma cells (Nimmerjahn and Ravetch, 2008; Tackenberg et al., 2010).”
BackgroundCurrent and Potential Uses of Immunocytokines as Cancer Immunotherapy
Sondel, P. M., & Gillies, S. D. (2012) · Antibodies · doi:10.3390/antib1020149 · Cited by 38
“While there is a family of FcγRs on leukocytes [11], the most important for ADCC are the FcR2a (CD32) FcRs expressed primarily on neutrophils, monocytes and macrophages, and the”
Backgroundvan der Heijden, J., Nagelkerke, S. Q., Zhao, X., Geissler, J., Rispens, T., van den Berg, T. K., & Kuijpers, T. W. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1203570 · Cited by 37
“although most immune cells express multiple FcgRs with different affinities for IgG and different downstream signaling pathways, some activating and some inhibitory (29).”
BackgroundEnhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells
Bonsmann, M. S. G., Niezold, T., Temchura, V., Pissani, F., Ehrhardt, K., Brown, E. P., Osei‐Owusu, N. Y., Hannaman, D., Hengel, H., Ackerman, M. E., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501377 · Cited by 46
Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity
Ackerman, M. E., & Alter, G. (2013) · Current HIV Research · doi:10.2174/1570162x113116660058 · Cited by 40
Tam, S. H., McCarthy, S. G., Armstrong, A., Somani, S., Wu, S., Liu, X., Gervais, A., Ernst, R., Saro, D., Decker, R., et al. (2017) · Antibodies · doi:10.3390/antib6030012 · Cited by 44
Immune Effector Functions of Human IgG2 Antibodies against EGFR
Rösner, T., Kahle, S., Montenegro, F., Matlung, H. L., Jansen, J. H. M., Evers, M., Beurskens, F. J. M., Leusen, J. H. W., van den Berg, T. K., & Valerius, T. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0341 · Cited by 42
“Human myeloid cells express a panel of molecularly and functionally distinct receptors for IgG (8, 9).”
BackgroundKim, D., Lee, S., & Na, K. (2021) · Small · doi:10.1002/smll.202006650 · Cited by 41
Keeler, S. P., & Fox, J. M. (2021) · Viruses · doi:10.3390/v13061037 · Cited by 42
Extracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 41
“, 2019), playing a pivotal role in phagocytosis and cytokine stimulation (Tridandapani and Anderson, 2008; Nimmerjahn and Ravetch, 2008).”
BackgroundGu, W., Feng, L., Yu, H., Tian, Z., Huang, M., Wang, Y., Niu, J., Luo, X., Guo, L., & Ren, L. (2015) · Journal of General Virology · doi:10.1099/vir.0.000118 · Cited by 42
Wang, W., Sun, L., Li, T., Ma, Y., Li, J., Liu, Y., Li, M., Wang, L., Li, C., Xie, Y., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1134409 · Cited by 37
Zheng, W., Zhou, T., Zhang, Y., Ding, J., Xie, J., Wang, S., Wang, Z., Wang, K., Shen, L., Zhu, Y., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122247 · Cited by 41
Frampton, S., Smith, R., Ferson, L., Gibson, J., Hollox, E. J., Cragg, M. S., & Strefford, J. C. (2024) · Immunological Reviews · doi:10.1111/imr.13401 · Cited by 47
“5 Consequently, in conjunction with the varying affinities of different IgG isotypes for various Fc γ R and cell context-dependent intracellular signaling pathways, the tight regulation of Fc γ R expression and activation ensures an appropriate and coordinated immune response.”
Challenges and prospects in HER2-positive breast cancer-targeted therapy
Li, X., Zhang, X., Yin, S., & Nie, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104624 · Cited by 43
Marjon, K. D., Marnell, L. L., Mold, C., & Clos, T. W. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1397 · Cited by 36
“Syk then phosphorylates adaptor proteins, which are necessary for downstream signaling events (23).”
BackgroundNi, W., Bones, J., & Karger, B. L. (2013) · Analytical Chemistry · doi:10.1021/ac3031898 · Cited by 36
Rayner, L., Hui, G. K., Gor, J., Heenan, R. K., Dalby, P. A., & Perkins, S. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572404 · Cited by 38
“The Fc glycan interactions with Fc R are important to stabilize the interaction (65, 66).”
BackgroundTilley, D. O., Arman, M., Smolenski, A., Cox, D. M., O’Donnell, J. S., Douglas, C. W. I., Watson, S. P., & Kerrigan, S. W. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12175 · Cited by 37
The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation
Olivares, N., Marquina, B., Mata‐Espinosa, D., Zatarain-Barrón, Z. L., Espitia-Pinzón, C., Estrada, I., Parada, C., Collin, M., Rook, G. A. W., & Hernández‐Pando, R. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12069 · Cited by 37
Aberrant B Cell Selection and Activation in Systemic Lupus Erythematosus
Kil, L. P., & Hendriks, R. W. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.786712 · Cited by 41
Licărete, E., Ganz, S., Recknagel, M. J., Zenzo, G. D., Hashimoto, T., Hertl, M., Zambruno, G., Hundorfean, G., Mudter, J., Neurath, M. F., et al. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-16 · Cited by 37
“Inadvertent autoimmune responses may be uncoupled from disease by various mechanisms, including cryptic B cell autoepitopes, typically seen in Goodpasture syndrome [39,40], anatomic, cellular and molecular barriers that avert either tissue deposition of immune complexes [42,43] or the engagement of inflammatory effect…”
BackgroundLow Copy Number of the Fc-γ Receptor 3B Gene FCGR3B Is a Risk Factor for Primary Sjögren’s Syndrome
Nossent, J. C., Rischmueller, M., & Lester, S. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120294 · Cited by 37
Targeting FcγRs to treat antibody-dependent autoimmunity
Yu, X., & Lazarus, A. H. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.006 · Cited by 36
Furuyama, W., Marzi, A., Carmody, A., Maruyama, J., Kuroda, M., Miyamoto, H., Nanbo, A., Manzoor, R., Yoshida, R., Igarashi, M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006139 · Cited by 36
“These signaling pathways are known to be important for the induction of phagocytic and endocytic processes to internalize immune complexes [21,25,26].”
BackgroundInfluentialTargeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
Kasturirangan, S., Rainey, G. J., Xu, L., Wang, X., Portnoff, A. D., Chen, T. X., Fazenbaker, C. A., Zhong, H., Bee, J. S., Zeng, Z., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770628 · Cited by 39
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
Amon, L., Hatscher, L., Heger, L., Dudziak, D., & Lehmann, C. H. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070663 · Cited by 41
Qiu, W., Yu, T., & Deng, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.924766 · Cited by 39
“Inflammation is the pathological basis of organ and tissue damage caused by the local deposition of IgG and immune complexes (ICs) (12–17).”
BackgroundInfluentialSaylor, C., Dadachova, E., & Casadevall, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902752 · Cited by 47
Xu, L., Li, G., Wang, J., Fan, Y., Wan, Z., Zhang, S., Shaheen, S., Li, J., Wang, L., Yue, C., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400101 · Cited by 36
Williams, E. L., Tutt, A. L., Beers, S. A., French, R. R., Chan, H. T. C., Cox, K. L., Roghanian, A., Penfold, C. A., Butts, C. L., Boross, P., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301430 · Cited by 37
“plasma cells, macrophages, DCs, Kupffer cells, Langerhans cells, basophils, mast cells (4), sinusoidal lining cells in the liver (64), dermal microvascular endothelial cells (65), and placental villus endothelium (66).”
BackgroundMolecular modeling of antibodies for the treatment of TNF α ‐related immunological diseases
Pierri, C. L., Bossis, F., Punzi, G., Grassi, A., Cetrone, M., Parisi, G., & Tricarico, D. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.197 · Cited by 40
“Nevertheless, mAbs–Fc receptor interactions are crucial for the activation of the immune response (Nimmerjahn and Ravetch 2008).”
BackgroundKnorr, D. A., Blanchard, L., Leidner, R. S., Jensen, S. M., Meng, R., Jones, A., Ballesteros‐Merino, C., Bell, R. B., Baez, M., Marino, A. E., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0389 · Cited by 41
Self-citationWaning immunity and IgG4 responses following bivalent mRNA boosting
Lasrado, N., Collier, A.-R. Y., Miller, J. J., Hachmann, N. P., Liu, J., Anand, T., Bondzie, E. A., Fisher, J. L., Mazurek, C. R., Patio, R. C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj9945 · Cited by 43
Intravenous immunoglobulin as a therapy for autoimmune conditions
Danieli, M. G., Antonelli, E., Gammeri, L., Longhi, E., Cozzi, M. F., Palmeri, D., Gangemi, S., & Shoenfeld, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103710 · Cited by 35
Maurer, S., Steinbacher, J., Schmiedel, B. J., Kousis, P. C., Steinle, A., Jung, G., Große‐Hovest, L., & Salih, H. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400872 · Cited by 40
Steinbacher, J., Baltz‐Ghahremanpour, K., Schmiedel, B. J., Steinle, A., Jung, G., Kübler, A., Andre, M. C., Große‐Hovest, L., & Salih, H. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29083 · Cited by 35
Andersen, J. T., Foss, S., Kenanova, V. E., Olafsen, T., Leikfoss, I. S., Roopenian, D. C., Wu, A. M., & Sandlie, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355131 · Cited by 35
“Five mutant variants were constructed by site-directed mutagenesis; Ile-253 in the CH2-domain was mutated to alanine (I253A), His-310 and His-435 within the CH3 domain were mutated to alanine, glutamine, or arginine (H310A, H435Q, and H435R), respectively.”
BackgroundInfluentialWild, J. S., Schmiedel, B. J., Maurer, A., Raab, S., Prokop, L., Stevanović, S., Dörfel, D., Schneider, P., & Salih, H. R. (2015) · Leukemia · doi:10.1038/leu.2015.50 · Cited by 36
Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
Liu, X., Liu, Y., & Chen, F. (2016) · Oncotarget · doi:10.18632/oncotarget.12533 · Cited by 36
“FcγRIIB has an immunoreceptor tyrosine-based inhibition motif (ITIM) in its intracytoplasmic domain [40], and is the only FcγR that has an inhibitory function [41].”
BackgroundStamou, M., Grodzki, A. C., van Oostrum, M., Wollscheid, B., & Lein, P. J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1050-z · Cited by 37
Bonegio, R. G. B., Lin, J. D., Beaudette-Zlatanova, B. C., York, M. R., Menn‐Josephy, H., & Yasuda, K. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800300 · Cited by 37
FcγRIIb differentially regulates pre-immune and germinal center B cell tolerance in mouse and human
Espéli, M., Bashford-Rogers, R. J. M., Sowerby, J. M., Alouche, N., Wong, L., Denton, A. E., Linterman, M. A., & Smith, K. G. C. (2019) · Nature Communications · doi:10.1038/s41467-019-09434-0 · Cited by 35
Novel functions of inactive rhomboid proteins in immunity and disease
Geesala, R., Issuree, P. D. A., & Maretzky, T. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3vmr0219-069r · Cited by 40
Li, M., Kim, S., Lee, A., Shrinidhi, A., Ko, Y. H., Lim, H. G., Kim, H. H., Bae, K. B., Park, K. M., & Kim, K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b16283 · Cited by 35
IgG Immune Complexes Break Immune Tolerance of Human Microglia
van der Poel, M., Hoepel, W., Hamann, J., Huitinga, I., & den Dunnen, J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000130 · Cited by 37
Role of the complement system in antibody-dependent enhancement of flavivirus infections
Byrne, A. B., & Talarico, L. B. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.039 · Cited by 42
Tim4 Recognizes Carbon Nanotubes and Mediates Frustrated Phagocytosis Leading to Granuloma Formation
Omori, S., Tsugita, M., Hoshikawa, Y., Morita, M., Ito, F., Yamaguchi, S.-I., Xie, Q., Noyori, O., Yamaguchi, T., Takada, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.108734 · Cited by 38
Mijakovac, A., Jurić, J., Kohrt, W. M., Krištić, J., Kifer, D., Gavin, K. M., Miškec, K., Frkatović-Hodžić, A., Vučković, F., Pezer, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680227 · Cited by 39
“Glycans attached to the Fc part of the IgG molecule affect interactions with different Fc receptors, which is why changes in glycosylation have direct effects on the immune system at multiple levels (2).”
BackgroundKo, Y., Yu, Y., Wu, Y.-F., Tseng, Y.-C., Chen, C.-L., Goh, K.-S., Liao, H.-Y., Chen, T.-H., Cheng, T.-J. R., Yang, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009724 · Cited by 38
“After washing with PBST (PBS + 0.01% Tween 20), the secondary antibody (rabbit anti-goat IgG HRP conjugated) was added and incubated for 1 h at 37˚C. Peroxidase substrate solution PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009724 August 5, 2021 13 / 20 was then added and incubated for 15 min at room temper…”
BackgroundInfluentialStrategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy
Lu, Y., Shi, Y., & You, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.011 · Cited by 35
Antibody Delivery of Drugs and Radionuclides: Factors Influencing Clinical Pharmacology
Prabhu, S., Boswell, C. A., Leipold, D. D., Khawli, L. A., Li, D., Lü, D., Theil, F., Joshi, A., & Lum, B. L. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.41 · Cited by 37
Neves, P., dos Santos, J. R., Tubarão, L. N., Bonaldo, M. C., & Galler, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081953 · Cited by 41
Role of B Cells and Antibodies in Acquired Immunity against Mycobacterium tuberculosis
Achkar, J. M., Chan, J., & Casadevall, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018432 · Cited by 43
“Abs have many mechanisms by which they can modify the outcome of bacterial intracellular pathogenesis, ranging from opsonization to signaling through Fc receptors (FcRs) (reviewed in Casadevall 1998, 2003; Nimmerjahn and Ravetch 2008).”
BackgroundMing‐Lum, A., Shojania, S., So, E., McCarrell, E., Shaw, E., Vu, D., Wang, I., McIntosh, L. P., & Mui, A. L. ‐. (2012) · The FASEB Journal · doi:10.1096/fj.11-201475 · Cited by 34
FcRn Inhibitor Therapies in Neurologic Diseases
Alfaidi, N., Karmastaji, S. M., Matic, A. E., & Bril, V. (2024) · CNS Drugs · doi:10.1007/s40263-024-01090-3 · Cited by 38
[Cells of innate and adaptive immunity in type 2 diabetes and obesity].
Guzmán‐Flores, J. M., & López-Briones, S. (2012) · PubMed · Cited by 50
The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
Griggs, J., & Zinkewich-Peotti, K. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605349 · Cited by 36
“The mechanisms by which Fc–Fc-receptor interactions regulate immune responses to effect tumour cell death have been extensively reviewed elsewhere (Nimmerjahn and Ravetch, 2008).”
Modulation of tumor immunity by therapeutic monoclonal antibodies
Abès, R., & Teillaud, J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9282-3 · Cited by 37
“Furthermore, following the IgG-FcγR interaction occurring in mAb-mediated phagocytosis, DC activity can be finely tuned, influencing both the nature and the polarization of the induced immune response downstream [30, 32 ].”
BackgroundPanchanathan, R., Shen, H., Duan, X., Rathinam, V. A. K., Erickson, L. D., Fitzgerald, K. A., & Choubey, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003638 · Cited by 34
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.